Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study

Abstract Background In China many respiratory pathogens stayed low activities amid the COVID-19 pandemic due to strict measures and controls. We here aimed to study the epidemiological and clinical characteristics of pediatric inpatients with Mycoplasma pneumoniae pneumonia (MPP) after the mandatory...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuqian Zhang, Chenglei Su, Yang Zhang, Shuo Ding, Xianliang Yan, Jianguo Zhang, Zhimin Tao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-024-10370-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559825352228864
author Yuqian Zhang
Chenglei Su
Yang Zhang
Shuo Ding
Xianliang Yan
Jianguo Zhang
Zhimin Tao
author_facet Yuqian Zhang
Chenglei Su
Yang Zhang
Shuo Ding
Xianliang Yan
Jianguo Zhang
Zhimin Tao
author_sort Yuqian Zhang
collection DOAJ
description Abstract Background In China many respiratory pathogens stayed low activities amid the COVID-19 pandemic due to strict measures and controls. We here aimed to study the epidemiological and clinical characteristics of pediatric inpatients with Mycoplasma pneumoniae pneumonia (MPP) after the mandatory COVID-19 restrictions were lifted, in comparison to those before the COVID-19 pandemic. Methods We here included 4,296 pediatric patients with MPP, hospitalized by two medical centers in Jiangsu Province, China, from January 2015 to March 2024. Patients were divided into the pre-COVID (n = 1,662) and post-COVID (n = 2,634) groups. Their baseline characteristics, laboratory test results and radiological patterns were separately assessed and compared between the two groups to determine the substantial changes in the disease profile of MPP after the COVID-19 pandemic. Results Epidemiological results suggested a higher annual incidence of MPP after the COVID-19 pandemic when the outbreak reached a peak in October, two months delayed in seasonality compared to that in the pre-COVID era. For pediatric patients with MPP, there was no difference in their median ages, gender ratios, and severe case percentages between the two groups, where most patients were younger than 14 years old. With significance, the post-COVID group had more occurrences of cough and expectoration and higher incidences of influenza A/B virus (IAV/IBV) co-infection than the pre-COVID group. Many hematological parameters and radiological features between the two groups displayed alteration, but comparatively there demonstrated no worsened severity in hospitalized children with MPP after COVID-19 pandemic. Concurrently, the post-COVID group was administered with fewer antibiotics but more corticosteroids for effective treatment than the pre-COVID group. Conclusion Through the COVID-19 pandemic, the epidemiological and clinical characteristics of pediatric patients with MPP differed, but there was no evident change in the disease severity. After the COVID-19 pandemic, the increased incidence of IAV/IBV co-infection may contribute to the differences in clinical symptoms and hematological profiles, while the adding usage of corticosteroids might treat more effectively.
format Article
id doaj-art-8f20c579d63548179106c6a9303c66e0
institution Kabale University
issn 1471-2334
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-8f20c579d63548179106c6a9303c66e02025-01-05T12:09:43ZengBMCBMC Infectious Diseases1471-23342025-01-0125111310.1186/s12879-024-10370-8Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter studyYuqian Zhang0Chenglei Su1Yang Zhang2Shuo Ding3Xianliang Yan4Jianguo Zhang5Zhimin Tao6Department of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityDepartment of Emergency Medicine, Affiliated Hospital of Xuzhou Medical UniversityDepartment of Emergency Medicine, Suining County People’s HospitalDepartment of Emergency Medicine, Fengxian County People’s HospitalDepartment of Emergency Medicine, Affiliated Hospital of Xuzhou Medical UniversityDepartment of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityDepartment of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityAbstract Background In China many respiratory pathogens stayed low activities amid the COVID-19 pandemic due to strict measures and controls. We here aimed to study the epidemiological and clinical characteristics of pediatric inpatients with Mycoplasma pneumoniae pneumonia (MPP) after the mandatory COVID-19 restrictions were lifted, in comparison to those before the COVID-19 pandemic. Methods We here included 4,296 pediatric patients with MPP, hospitalized by two medical centers in Jiangsu Province, China, from January 2015 to March 2024. Patients were divided into the pre-COVID (n = 1,662) and post-COVID (n = 2,634) groups. Their baseline characteristics, laboratory test results and radiological patterns were separately assessed and compared between the two groups to determine the substantial changes in the disease profile of MPP after the COVID-19 pandemic. Results Epidemiological results suggested a higher annual incidence of MPP after the COVID-19 pandemic when the outbreak reached a peak in October, two months delayed in seasonality compared to that in the pre-COVID era. For pediatric patients with MPP, there was no difference in their median ages, gender ratios, and severe case percentages between the two groups, where most patients were younger than 14 years old. With significance, the post-COVID group had more occurrences of cough and expectoration and higher incidences of influenza A/B virus (IAV/IBV) co-infection than the pre-COVID group. Many hematological parameters and radiological features between the two groups displayed alteration, but comparatively there demonstrated no worsened severity in hospitalized children with MPP after COVID-19 pandemic. Concurrently, the post-COVID group was administered with fewer antibiotics but more corticosteroids for effective treatment than the pre-COVID group. Conclusion Through the COVID-19 pandemic, the epidemiological and clinical characteristics of pediatric patients with MPP differed, but there was no evident change in the disease severity. After the COVID-19 pandemic, the increased incidence of IAV/IBV co-infection may contribute to the differences in clinical symptoms and hematological profiles, while the adding usage of corticosteroids might treat more effectively.https://doi.org/10.1186/s12879-024-10370-8Mycoplasma pneumoniaePneumoniaPediatric hospitalizationCOVID-19 pandemicMacrolide resistance
spellingShingle Yuqian Zhang
Chenglei Su
Yang Zhang
Shuo Ding
Xianliang Yan
Jianguo Zhang
Zhimin Tao
Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
BMC Infectious Diseases
Mycoplasma pneumoniae
Pneumonia
Pediatric hospitalization
COVID-19 pandemic
Macrolide resistance
title Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
title_full Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
title_fullStr Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
title_full_unstemmed Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
title_short Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
title_sort epidemiological and clinical characteristics of hospitalized pediatric patients with mycoplasma pneumoniae pneumonia before and after the covid 19 pandemic in china a retrospective multicenter study
topic Mycoplasma pneumoniae
Pneumonia
Pediatric hospitalization
COVID-19 pandemic
Macrolide resistance
url https://doi.org/10.1186/s12879-024-10370-8
work_keys_str_mv AT yuqianzhang epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy
AT chengleisu epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy
AT yangzhang epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy
AT shuoding epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy
AT xianliangyan epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy
AT jianguozhang epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy
AT zhimintao epidemiologicalandclinicalcharacteristicsofhospitalizedpediatricpatientswithmycoplasmapneumoniaepneumoniabeforeandafterthecovid19pandemicinchinaaretrospectivemulticenterstudy